855303-RNA Biomarker Validation

Enrolling by invitationOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Fractures, Bone
Interventions
OTHER

Blood draws to assess RNA expression levels

None. Standard of Care (SOC) only.

Trial Locations (2)

19104

University of Pennsylvania, Philadelphia

95817

University of California, Davis Medical Center, Sacramento

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PharPoint Research, Inc.

INDUSTRY

collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

Cooperative Human Tissue Network - Eastern Division (CHTN-ED)

UNKNOWN

collaborator

Osetomics, LLC

UNKNOWN

collaborator

Resonant Clinical/Therapak, Claremont, California

UNKNOWN

lead

University of Pennsylvania

OTHER